UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

The lancet oncology, 2022-01, Vol.23 (1), p.91-103

2022

Volltextzugriff (PDF)

Revving the CAR – Combination strategies to enhance CAR T cell effectiveness

Blood reviews, 2021-01, Vol.45, p.100695, Article 100695

2021

Volltextzugriff (PDF)

Peripheral blood stem cell grafts in allogeneic hematopoietic cell transplantation: It is not all about the CD34+ cell dose

Transfusion and apheresis science, 2021-02, Vol.60 (1), p.103081-103081, Article 103081

Reshef, Ran

2021

Volltextzugriff (PDF)

Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation

Clinics in chest medicine, 2017-12, Vol.38 (4), p.771-783

2017

Volltextzugriff (PDF)

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Biology of blood and marrow transplantation, 2016-01, Vol.22 (1), p.4-10

2016

Volltextzugriff (PDF)

Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases

The Journal of heart and lung transplantation, 2012-03, Vol.31 (3), p.296-304

2012

Volltextzugriff (PDF)

Precision in donor selection: Identifying ideal stem-cell donors through their T cells

Experimental hematology, 2016-11, Vol.44 (11), p.1020-1023

2016

Volltextzugriff (PDF)

Improved accuracy of acute graft-versus-host disease staging among multiple centers

Best practice & research. Clinical haematology, 2014-09, Vol.27 (3), p.283-287

2014

Volltextzugriff (PDF)

Posttransplant Lymphoproliferative Disorder Following Kidney Transplant

American journal of kidney diseases, 2010-01, Vol.55 (1), p.168-180

2010

Volltextzugriff (PDF)

Standardized Semi-structured Psychosocial Evaluation before Hematopoietic Stem Cell Transplantation Predicts Patient Adherence to Post-Transplant Regimen

Biology of blood and marrow transplantation, 2019-11, Vol.25 (11), p.2222-2227

2019

Volltextzugriff (PDF)

Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats

Atherosclerosis, 2007-10, Vol.194 (2), p.357-363

2007

Volltextzugriff (PDF)

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

Biology of blood and marrow transplantation, 2018-06, Vol.24 (6), p.1274-1280

2018

Volltextzugriff (PDF)

P-054 Abnormal Serum Fixation Pattern Are a Common Event Following BCMA CAR-T in Relapsed Refractory Multiple Myeloma and Are Often Preceded by Immunological Events

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S72-S73

2024

Volltextzugriff (PDF)

OA-07 A Comparison of Standard of Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel CAR T-cell Therapy in Relapsed or Refractory Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S5-S5

2024

Volltextzugriff (PDF)

P-053 Early Absolute Lymphocyte Count after BCMA CAR-T as a Surrogate for CAR-T Expansion, Response, and Progression Free Survival in Multiple Myeloma

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S71-S72

2024

Volltextzugriff (PDF)

OA-11 Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel (Cilta-cel) for Relapsed/Refractory Multiple Myeloma (RRMM): Real World Experience With Updated Follow-up

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S7-S8

2024

Volltextzugriff (PDF)

Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2013-07, Vol.19 (7), p.1094-1101

2013

Volltextzugriff (PDF)

IBCL-124: Interim Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL)

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S278-S278

2020

Volltextzugriff (PDF)

Fertility Concerns and Access to Care for Stem Cell Transplantation Candidates with Sickle Cell Disease

Biology of blood and marrow transplantation, 2020-08, Vol.26 (8), p.e192-e197

2020

Volltextzugriff (PDF)

Higher Apheresis Blood Volumes Are Associated with a Reduction in Relapse Risk and Improved Survival in Patients Undergoing Reduced Intensity Allogeneic Transplants from Unrelated Donors, Potentially Due to Higher CD8 T-Cell Doses

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S311-S312

2016

Volltextzugriff (PDF)

Pharamacodynamic Assessment Shows That CCR5 Surface Expression May Serve As an Indicator for Effective CCR5 Blockade in Allogeneic Stem Cell Transplant (alloSCT) Recipients Treated with Maraviroc

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S332-S333

2015

Volltextzugriff (PDF)

Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S369-S369

2015

Volltextzugriff (PDF)

An Evaluation of a Pharmacokinetic Interaction Between Tacrolimus and Maraviroc in Allogeneic Stem Cell Transplant Recipients

Biology of blood and marrow transplantation, 2014-02, Vol.20 (2), p.S289-S289

2014

Volltextzugriff (PDF)

Acute Cholecystitis Is a Common Complication after Allogeneic Stem Cell Transplantation and Is Associated with the Use of Total Parenteral Nutrition

Biology of blood and marrow transplantation, 2015-04, Vol.21 (4), p.768-771

2015

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

KollektionEbook Central Perpetual and DDA

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Hematology, Oncology And Palliative Medicine
(19)
Hematology
(18)
Humans
(16)
Transplantation
(14)
Immunology
(13)
Aged
(12)
Male
(12)
Middle Aged
(11)
Female
(10)
Adult
(9)
Hematopoietic Stem Cell Transplantation - Methods
(8)
Treatment Outcome
(7)
Graft Vs Host Disease - Prevention & Control
(5)
Recurrence
(5)
Transplantation Conditioning - Methods
(5)
Transplantation, Homologous
(5)
Young Adult
(5)
Gvhd
(4)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Access via ScienceDirect (Elsevier)
(63)
Ingenta Connect
(57)
EZB-NALI5-00465 Elsevier Archive NL
(53)
EZB-FREE-00999 freely available EZB journals
(48)
Single Journals
(48)
MEDLINE
(18)
Journals@Ovid
(5)
IngentaConnect Journals
(1)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

Revving the CAR – Combination strategies to enhance CAR T cell effectiveness

Peripheral blood stem cell grafts in allogeneic hematopoietic cell transplantation: It is not all about the CD34+ cell dose

Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation

International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases

Precision in donor selection: Identifying ideal stem-cell donors through their T cells

Improved accuracy of acute graft-versus-host disease staging among multiple centers

Posttransplant Lymphoproliferative Disorder Following Kidney Transplant

Standardized Semi-structured Psychosocial Evaluation before Hematopoietic Stem Cell Transplantation Predicts Patient Adherence to Post-Transplant Regimen

Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial

P-054 Abnormal Serum Fixation Pattern Are a Common Event Following BCMA CAR-T in Relapsed Refractory Multiple Myeloma and Are Often Preceded by Immunological Events

OA-07 A Comparison of Standard of Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel CAR T-cell Therapy in Relapsed or Refractory Multiple Myeloma

P-053 Early Absolute Lymphocyte Count after BCMA CAR-T as a Surrogate for CAR-T Expansion, Response, and Progression Free Survival in Multiple Myeloma

OA-11 Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel (Cilta-cel) for Relapsed/Refractory Multiple Myeloma (RRMM): Real World Experience With Updated Follow-up

Pilot Study of Prophylactic Ex Vivo Costimulated Donor Leukocyte Infusion After Reduced-Intensity Conditioned Allogeneic Stem Cell Transplantation

IBCL-124: Interim Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (R/R iNHL)

Fertility Concerns and Access to Care for Stem Cell Transplantation Candidates with Sickle Cell Disease

Higher Apheresis Blood Volumes Are Associated with a Reduction in Relapse Risk and Improved Survival in Patients Undergoing Reduced Intensity Allogeneic Transplants from Unrelated Donors, Potentially Due to Higher CD8 T-Cell Doses

Pharamacodynamic Assessment Shows That CCR5 Surface Expression May Serve As an Indicator for Effective CCR5 Blockade in Allogeneic Stem Cell Transplant (alloSCT) Recipients Treated with Maraviroc

Higher Tacrolimus Concentrations Early Post-Transplant Reduce the Risk of Acute Graft-Versus-Host Disease in Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation

An Evaluation of a Pharmacokinetic Interaction Between Tacrolimus and Maraviroc in Allogeneic Stem Cell Transplant Recipients

Acute Cholecystitis Is a Common Complication after Allogeneic Stem Cell Transplantation and Is Associated with the Use of Total Parenteral Nutrition

Aktive Filter

Suchergebnisse filtern